INFORMED.
LIVE

Akums Drugs and Pharmaceuticals Limited

BSE: AKUMS544222ISIN INE09XN01023
  • Healthcare
  • Pharmaceuticals
  • BSE 1000

Share price

₹783.95+17.80 (+2.32%)
as of 18 Sep 2026
Akums Drugs and Pharmaceuticals Limited share price, 18 Sep 2025 to 18 Sep 2026: ₹475.30 to ₹783.95 (+64.9%). Low ₹414.30, high ₹783.95. Volume shown below the price.
52W high
₹796.20
52W low
₹410.10
Off 52W high
-1.54%
1M return
+4.19%
3M return
+29.86%
6M return
+62.06%
1Y return
+64.94%
20D avg volume
15,384
50 DMA
₹725.07
200 DMA
₹556.24

Key ratios Consolidated

Market cap
₹12,339 Cr
Current price
₹783.95
52W high / low
₹796.20 / ₹410.10
Face value
₹2.00
P/E
42.16
P/B
EPS (TTM)
₹18.60
Book value / share
ROE
ROCE
10.90%
Operating margin
Net margin
Debt / equity
0.02
Net debt
₹-313.05 Cr
Interest cover
5.06
Dividend yield
0.38%
Dividend / share (TTM)
₹3.00
Payout
16.13%
Cash conversion cycle
79.6 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
1,1671,1581,1601,0181,0241,056
30.3835.3034.3332.3726.7317.55
1,0581,0701,076984.22955.121,006
682.12586.91611.25552.63547.90623.85
26.4962.9360.2956.7121.0819.49
201.43199.03189.38189.27176.14183.90
24.7623.8923.7423.3023.144.54
41.0640.1239.6537.8636.9240.00
145.09146.65144.77141.22137.00138.65
139.24123.01117.7965.6795.6566.92
0.00-1.80-18.230.000.008.22
139.24121.2299.5765.6795.6575.14
38.2639.8731.8922.9830.96-74.47
100.9881.3467.6742.7064.69149.61
6.535.534.332.664.159.64
Key metrics
205.06185.23162.96126.83155.71119.68
17.60%16.00%14.10%12.50%15.20%11.30%
8.70%7.00%5.80%4.20%6.30%14.20%
3.30%2.10%2.50%
13.90%9.70%
56.10%-45.60%
MetricTTMFY26FY25FY24
Income statement
4,5024,3594,118
132.38128.7252.12
4,1884,0863,842
2,4332,2992,254
206.42201.00181.47
779.11753.82715.82
95.6994.0734.60
158.69154.55153.45
577.73569.65504.42
445.71402.12328.56
-20.03-20.0216.70
425.70382.10345.25
133.00125.701.48
292.69256.40343.78
19.0516.6722.60
Key metrics
680.08630.72533.30
15.11%14.50%12.90%
6.50%5.90%8.30%
10.90%11.80%
5.80%
-25.40%
950.67192.88
4.611.35
0.020.00
-313.05-87.54
79.671.7
Balance sheet
5,4474,113
3,5602,275
386.00101.19
796.56770.30
755.71680.93
297.41198.80
1,4481,390
602.16642.78
1,095893.75
72.9513.65
72.9513.65
0.000.00
3,3313,064
Cash flow
1,181465.19
-930.27-547.84
33.8872.79
230.53272.31
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
392.27338.37368.61309.31332.44328.75
26.1027.7329.6027.0828.5532.05
359.04341.60358.54305.19301.49323.75
253.56212.81222.67202.31192.55207.06
0.000.000.000.000.000.00
58.9257.8854.8054.5850.7453.84
2.482.592.462.082.912.63
12.7912.4212.1510.6910.2510.09
48.1962.0454.7546.6342.7749.78
59.3424.5039.6731.2059.5137.05
0.00-2.71-3.810.000.000.00
59.3421.7935.8731.2059.5137.05
14.506.597.757.7414.649.47
44.8415.2028.1123.4644.8727.59
2.930.991.841.532.931.80
Key metrics
74.6136.8050.4843.9772.6749.77
19.00%10.90%13.70%14.20%21.90%15.10%
11.40%4.50%7.60%7.60%13.50%8.40%
1.00%1.40%1.70%
18.00%2.90%
-0.10%-44.90%
MetricTTMFY26FY25FY24
Income statement
1,4091,3491,312
110.51112.97124.19
1,3641,3071,228
891.35830.34811.06
0.000.000.00
226.18217.99201.74
9.6110.0415.31
48.0545.5039.55
211.61206.20170.54
154.71154.88207.84
-6.52-6.520.00
148.20148.37207.84
36.5836.7346.84
111.61111.64161.00
7.297.2910.76
Key metrics
205.86203.91262.70
14.61%15.10%20.00%
7.92%8.30%12.30%
6.30%9.40%
2.80%
-30.70%
-124.06-2.60
-0.020.57
0.010.00
-32.83-72.56
66.652.4
Balance sheet
2,8122,685
1,324833.18
46.3876.49
217.54206.14
229.93201.69
81.8248.75
403.53334.92
201.40219.56
304.00309.31
13.553.93
13.553.93
0.000.00
2,4282,305
Cash flow
-1.9991.00
-24.97-458.84
-3.15375.38
122.0793.60

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
75.27%
QuarterJune 2026December 2025September 2025
Promoter %75.27%75.27%75.27%
HolderTypeHoldingPreviousChange
AKUMS MASTER TRUST (Sanjeev Jain and Sandeep Jain)Promoter40.79%40.79%0.00%
Sandeep JainPromoter17.24%17.24%0.00%
Sanjeev JainPromoter17.23%17.23%0.00%
Franklin India Opportunites FundPublic4.19%4.18%+0.01%
Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) FundPublic3.14%4.89%-1.75%
Akums Employee Benefits TrustPublic2.73%2.73%0.00%
Clarus Capital IPublic2.17%1.80%+0.37%
Bandhan Small Cap FundPublic1.13%1.11%+0.02%
Lata JainPromoter Group0.01%0.01%0.00%
Kiran JainPromoter Group0.00%0.00%0.00%
Akome Lifecare Private LimitedPromoter Group0.00%0.00%0.00%
Archana JainPromoter Group0.00%0.00%0.00%
Akums FoundationPromoter Group0.00%0.00%0.00%
Shivangi JainPromoter Group0.00%0.00%0.00%
Rajesh SharmaPromoter Group0.00%0.00%0.00%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Corporate actions

PurposeEx dateRecord datePayment date
Final Dividend - Rs. - 1.00003 Jul 20263 Jul 2026
Special Dividend - Rs. - 2.00003 Jul 20263 Jul 2026

Board meetings

  • Board Meeting - Financial Results